| Genetic Study in Young Onset Parkinson's Disease (NCT01529970) | China Medical University Hospital | 2012-01-01 |
| A Multifactorial Exercise Program to Reduce Falls in People With Parkinson Disease (NCT02302144) | Boston University Charles River Campus | 2011-12-01 |
| Combined Deep Brain Stimulation for Parkinson's Disease (NCT01485276) | National Institute of Neurological Disorders and Stroke (NINDS) | 2011-11-08 |
| Providing Specialty Care to Individuals With Parkinsonism Directly in Their Homes Via Web-based Video Conferencing- A Comparative Effectiveness Study (NCT01476306) | Johns Hopkins University | 2011-11-01 |
| Assessment of Three-dimensional Vision Alteration in Parkinson Disease (NCT01620164) | University Hospital, Toulouse | 2011-11-01 |
| Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression (NCT01556100) | Chang Gung Memorial Hospital | 2011-11-01 |
| Behavioural Addiction and Genetics in Parkinson's Disease (NCT02319395) | Assistance Publique - Hôpitaux de Paris | 2011-11-01 |
| Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease (NCT01323699) | Michael E. DeBakey VA Medical Center | 2011-11-01 |
| Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias (NCT01385592) | Novartis Pharmaceuticals | 2011-11-01 |
| Emotion, Mood and Executive Function in Parkinson's Disease (PD) (NCT01385735) | St. Josef Hospital Bochum | 2011-10-01 |
| Cardiovascular Events in Parkinson's Disease Patients (NCT01545856) | GlaxoSmithKline | 2011-09-01 |
| Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a (NCT01461083) | Institute for Neurodegenerative Disorders | 2011-09-01 |
| LRRK2 Mutation and Parkinson's Disease (NCT01424475) | GlaxoSmithKline | 2011-08-11 |
| Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls (NCT01461109) | Institute for Neurodegenerative Disorders | 2011-08-01 |
| Trodat 1 SPECT and Dopamine Polymorphism (NCT01381302) | Wolfson Medical Center | 2011-08-01 |
| Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism (NCT01358474) | University of Minnesota | 2011-07-01 |
| Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm (NCT02814201) | Centre Hospitalier Universitaire, Amiens | 2011-07-01 |
| Natural History Study of Synucleinopathies (NCT01799915) | NYU Langone Health | 2011-06-01 |
| Functional Connectivity Parkinson Disease (NCT01798563) | University of Colorado, Denver | 2011-06-01 |
| Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects (NCT01520987) | Bial - Portela C S.A. | 2011-05-01 |
| Virtual Reality in Motor Performance and Quality of Life in Patients With Parkinson's Disease (NCT01120392) | Federal University of Bahia | 2011-05-01 |
| Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects (NCT01462708) | Institute for Neurodegenerative Disorders | 2011-05-01 |
| a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients (NCT01361009) | Boehringer Ingelheim | 2011-05-01 |
| Effects of Vitamin D in Parkinson's Disease (PD) (NCT01119131) | VA Office of Research and Development | 2011-05-01 |
| PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2) (NCT01536821) | Indiana University | 2011-05-01 |
| Electrophysiology of Brain Activity During Electrode Implantation in Patients Treated With Deep Brain Stimulation (NCT03874611) | University Hospital, Grenoble | 2011-04-13 |
| Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease (NCT01662414) | Chulalongkorn University | 2011-04-01 |
| A Study to Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512) (NCT01323855) | Merck Sharp & Dohme LLC | 2011-03-28 |
| A Study to Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging (NCT01264861) | Newron Pharmaceuticals SPA | 2011-03-01 |
| Abnormal Movements, Cerebellum and Sensorimotor : Oculomotor Study (NCT01495897) | Institut National de la Santé Et de la Recherche Médicale, France | 2011-03-01 |
| Bee Venom for the Treatment of Parkinson Disease (NCT01341431) | Assistance Publique - Hôpitaux de Paris | 2011-03-01 |
| Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy. (NCT01380899) | Universidad Autonoma de San Luis Potosí | 2011-02-01 |
| Clinical Outcomes for Deep Brain Stimulation (NCT03992625) | Washington University School of Medicine | 2011-01-03 |
| Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation (NCT01272687) | CENTOGENE GmbH Rostock | 2011-01-01 |
| Biofeedback-based Motor Learning to Ameliorate Freezing of Gait (NCT01223781) | Tel-Aviv Sourasky Medical Center | 2011-01-01 |
| Validation of a Diagnostic Self-assessment Scale Non-motor Fluctuations at the Parkinson's Patient (NCT02859805) | Assistance Publique Hopitaux De Marseille | 2011-01-01 |
| Varenicline for Gait and Balance Impairment in Parkinson Disease (NCT01341080) | Rush University Medical Center | 2010-12-28 |
| Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037) (NCT01227265) | Merck Sharp & Dohme LLC | 2010-11-19 |
| An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153) (NCT01215227) | Merck Sharp & Dohme LLC | 2010-11-18 |
| Pilot Study of Maintenance Therapy With Intravenous AMANTADINE (NCT01190553) | Rabin Medical Center | 2010-11-01 |
| Effects of Different Percentages Body Weight Supported Treadmill Training on Gait, Balance, Quality of Life and Fatigue in Parkinson's Disease (NCT03799887) | Hitit University | 2010-10-20 |
| Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias (NCT01173731) | Novartis Pharmaceuticals | 2010-10-01 |
| Repetitive Transcranial Magnetic Stimulation With H-coil in Parkinson's Disease (rTMS-PD) (NCT04638777) | Giancarlo Comi | 2010-09-27 |
| Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528 (NCT01536574) | GlaxoSmithKline | 2010-09-02 |
| Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients (NCT01191944) | Boehringer Ingelheim | 2010-08-01 |
| Physiological Brain Atlas Development (NCT01210534) | Ohio State University | 2010-08-01 |
| A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938) (NCT01155466) | Merck Sharp & Dohme LLC | 2010-07-14 |
| A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664) (NCT01155479) | Merck Sharp & Dohme LLC | 2010-07-06 |
| Computer-based Cognitive Training for Parkinson Disease (NCT01121627) | Clalit Health Services | 2010-07-01 |
| Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects (NCT01435915) | GlaxoSmithKline | 2010-06-28 |
| Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease (NCT01227681) | Buddhist Tzu Chi General Hospital | 2010-06-01 |
| Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression (NCT01141023) | Ken Marek, MD | 2010-06-01 |
| Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation (NCT01022073) | VA Office of Research and Development | 2010-06-01 |
| Phosphorylation of ERK1/2 in Patients With Parkinson's Disease (NCT01142739) | University Hospital, Bordeaux | 2010-06-01 |
| Effect of BIA 9-1067 on Cardiac Repolarization in Healthy Adult Men and Women (NCT01532115) | Bial - Portela C S.A. | 2010-05-01 |
| Rasagiline for Gait Treatment (NCT01098396) | Tel-Aviv Sourasky Medical Center | 2010-05-01 |
| A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease (NCT01484990) | AbbVie | 2010-04-01 |
| Influence of Pramipexole Extended Release on Medication Adherence in Parkinson´s Disease (NCT01097421) | Boehringer Ingelheim | 2010-03-01 |
| Pedunculo-Pontin Nucleus (PPN) - Deep Brain Stimulation (DBS) in Gait and Balance Disturbance in Parkinson's Disease (PPN-GAB-PARK Study) (NCT00821743) | Centre Hospitalier Universitaire de Nice | 2010-03-01 |
| Effectiveness of Physiotherapy Interventions for Patients With Parkinson's Disease (NCT01076712) | Queen Elizabeth Hospital, Hong Kong | 2010-03-01 |
| Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics (NCT01089283) | Tel-Aviv Sourasky Medical Center | 2010-03-01 |
| Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives (NCT01089270) | Tel-Aviv Sourasky Medical Center | 2010-03-01 |
| Pacific Northwest Udall Center (PANUC) Clinical Core (NCT01720810) | University of Washington | 2010-03-01 |
| A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa (NCT01154166) | GlaxoSmithKline | 2010-02-15 |
| The Influence of Sensory Stimuli on Gait Imagery in Patients With Freezing of Gait (NCT01071590) | National Institute of Neurological Disorders and Stroke (NINDS) | 2010-02-01 |
| Study of Subthalamic Brain Stimulation in Parkinson Disease (PD) (NCT01113684) | University of Alabama at Birmingham | 2010-02-01 |
| Effects of Walking and Respiratory Muscle Training on Pulmonary Function and Functional Exercise Capacity in PD (NCT04834258) | Marmara University | 2010-01-05 |
| Study of Sexuality in Parkinson Disease (NCT01878409) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2010-01-01 |
| Effects Of tDCS With Physical Therapy On Rehabilitation In Parkinson's Disease (NCT01877148) | Universidade Federal de Pernambuco | 2010-01-01 |
| Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases (NCT01954875) | Wake Forest University Health Sciences | 2009-12-02 |
| Naltrexone for Impulse Control Disorders in Parkinson's Disease (NCT01052831) | University of Pennsylvania | 2009-11-01 |
| Effect of Rasagiline on BIA 9-1067 Pharmacokinetics (NCT01532141) | Bial - Portela C S.A. | 2009-11-01 |
| Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic (NCT01519284) | Bial - Portela C S.A. | 2009-11-01 |
| Deep Brain Stimulation (DBS) Frequency Effects on Gait in Parkinson's Disease(PD) (NCT00993291) | Vanderbilt University | 2009-11-01 |
| Effect of BIA 9-1067 on Rasagiline Pharmacokinetics (NCT01532128) | Bial - Portela C S.A. | 2009-11-01 |
| Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions (NCT01028209) | Institute for Neurodegenerative Disorders | 2009-11-01 |
| Spectroscopy in Parkinson Disease (NCT01005030) | Molecular Biometrics, Inc. | 2009-10-01 |
| A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda (NCT01371682) | GlaxoSmithKline | 2009-09-18 |
| Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-daily (NCT00986245) | Seoul National University Hospital | 2009-09-01 |
| The Effects of Vitamin D and Bone Loss in Parkinson's Disease (NCT00907972) | Memorial Medical Center | 2009-09-01 |
| 50 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's Disease (NCT00977184) | National Institute of Neurological Disorders and Stroke (NINDS) | 2009-09-01 |
| Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease (NCT00986414) | Novartis | 2009-09-01 |
| Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions (NCT00970333) | Institute for Neurodegenerative Disorders | 2009-08-01 |
| Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects. (NCT00970229) | Institute for Neurodegenerative Disorders | 2009-07-01 |
| PD4PD:Partnered Dance for Parkinson Disease (NCT01388556) | Washington University School of Medicine | 2009-07-01 |
| Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease (NCT00909545) | Northwestern University | 2009-07-01 |
| Safety of Urate Elevation in Parkinson's Disease (NCT00833690) | The Parkinson Study Group | 2009-06-01 |
| Executive Control Analysis in Patients Suffering From Parkinson Disease and Treated by Deep Brain Stimulation (NCT00922909) | Assistance Publique Hopitaux De Marseille | 2009-06-01 |
| Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide (NCT01536366) | Bial - Portela C S.A. | 2009-06-01 |
| Biomarkers of Risk of Parkinson Disease (NCT00775853) | National Institute of Neurological Disorders and Stroke (NINDS) | 2009-05-27 |
| Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites (NCT01515891) | Bial - Portela C S.A. | 2009-05-01 |
| Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients (NCT00767546) | Rabin Medical Center | 2009-05-01 |
| Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550) (NCT00845000) | Merck Sharp & Dohme LLC | 2009-04-21 |
| Identification of Risk Factors Parkinson's Disease by Convergence Strategy (NCT03536104) | University Hospital, Lille | 2009-03-25 |
| Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease (NCT00823836) | GlaxoSmithKline | 2009-03-01 |
| Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide (NCT01533116) | Bial - Portela C S.A. | 2009-03-01 |
| Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa (NCT01533077) | Bial - Portela C S.A. | 2009-03-01 |
| A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions (NCT00870974) | Institute for Neurodegenerative Disorders | 2009-03-01 |
| Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease (NCT00806468) | Johannes Gutenberg University Mainz | 2009-02-01 |
| Effects of Aerobic Exercise in Parkinson's Disease (NCT00784563) | US Department of Veterans Affairs | 2009-02-01 |